Hera Biotech is developing the world's first non-surgical test for definitive diagnosis and staging of endometriosis. San Antonio-based medical ...
News
- Hera Biotech Closes Oversubscribed $1.9 Million Seed Raise For Novel Diagnostic ... - Benzinga
- LumaBridge Announces Growth Equity Investment From Summit Partners | National
SAN ANTONIO and BOSTON, Aug. ... LumaBridge serves as a strategic partner to emerging biopharma and biotech companies, offering full outsourced ...
- Study Reveals Benefits Of Robotic Surgery In Cases Of Advanced Kidney Cancer
... Mays Cancer Center and Department of Urology at UT Health San Antonio reveal that robotic ... Biotech Stocks Facing FDA Decision In March 2022.
- Legendary Hemisfair in San Antonio art gets some overdue TLC | TPR - Texas Public Radio
City of San Antonio. /. Workers detailing Juan O'Gorman's Confluence of Civilizations mural. It's one of San Antonio's ...
- Hera Biotech Closes Oversubscribed $1.9 Million Seed Raise For Novel ... - Business Wire
SAN ANTONIO--(BUSINESS WIRE)--San Antonio-based medical device start-up Hera Biotech has closed an oversubscribed $1.9 million seed financing ...